Enter assignee name

EPO Patents = 3

Forward Citations = 1

Loading Chart...

60 inventors (with patents filed for the assignee):

Krzysztof Matyszewski (3 out of 7 patents)

Marzena Mazur (3 out of 7 patents)

Robert Koralewski (3 out of 7 patents)

4. Sylwia Olejniczak (3 out of 8 patents)

5. Wojciech J Czestkowski (2 out of 6 patents)

6. Agnieszka Bartoszewicz (2 out of 5 patents)

7. Piotr Niedziejko (2 out of 2 patents)

8. Grzegorz Witkowski (2 out of 2 patents)

9. Magdalena Tyszkiewicz (2 out of 2 patents)

10. Marta Magdycz (2 out of 2 patents)

11. Marcin Zakrzewski (2 out of 2 patents)

12. Anna Gzik (1 out of 5 patents)

13. Adam A Golebiowski (1 out of 14 patents)

14. Julita Nowicka (1 out of 5 patents)

15. Bartlomiej Borek (1 out of 8 patents)

5 patents: Sort by Forward Citations

1. 12404279 - Deubiquitinase inhibitors and methods of use thereof (2025-09-02),

2. 12325701 - YKL-40 inhibitors and their therapeutic (2025-06-10),

3. 12319677 - Process for the production of 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methyl-morpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine (2025-06-03),

4. 11746107 - Process for the production of 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methyl-morpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine (2023-09-05),

5. 11638707 - Substituted amino triazoles useful as chitinase inhibitors (2023-05-02),

Molecure S.a. is a biopharmaceutical company focused on the discovery and development of innovative therapies for the treatment of cancer and other serious diseases. The company leverages advanced molecular technologies to create targeted treatments that aim to improve patient outcomes. With a commitment to scientific excellence and collaboration, Molecure is dedicated to addressing unmet medical needs through its robust pipeline of drug candidates and strategic partnerships in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

5 Patents

#19 in Warsaw

#62 in Poland

Warsaw, Poland

Molecure S.a.